Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before an...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a7d92086b044f65b70ec44572b7db46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6a7d92086b044f65b70ec44572b7db46 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6a7d92086b044f65b70ec44572b7db462021-11-25T17:04:43ZCan the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?10.3390/cancers132258512072-6694https://doaj.org/article/6a7d92086b044f65b70ec44572b7db462021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5851https://doaj.org/toc/2072-6694Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before and after adjuvant therapy. Of these patients, 85 had performed APA, and 53 had received only the usual therapy. HRs were recorded during the two tests. Results: Before starting chemotherapy, good agreement (intraclass correlation (ICC) 0.69; confidence interval at 95% IC<sub>0.95</sub> (0.591–0.769); <i>p</i> < 0.001) and a moderate correlation were evident between the 6MWT-HR and ventilatory threshold HR of the CPET (r = 0.70; <i>p</i> < 0.001). Good agreement and a high positive correlation were noted only in the group who engaged in APA (ICC 0.77; IC<sub>0.95</sub> (0.659–0.848); <i>p</i> < 0.001; r = 0.8; <i>p</i> < 0.01); moderate agreement and a moderate positive correlation were apparent in the control group (ICC 0.57; IC<sub>0.95</sub> (0.329–0.74); <i>p</i> < 0.001; r = 0.6; <i>p</i> < 0.01). The correlations were independent of age and body mass index. Conclusions: The 6MWT-HR can be used to prescribe exercise intensity for breast cancer patients both before and after specific treatment with concomitant APA.Nicole Tubiana-MathieuThibault CornetteStephane MandigoutSophie LeobonFrançois VincentLaurence VenatElise DelucheMDPI AGarticlecardiopulmonary testsix-minute walk testadapted physical activitybreast cancerhome trainingNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5851, p 5851 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cardiopulmonary test six-minute walk test adapted physical activity breast cancer home training Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
cardiopulmonary test six-minute walk test adapted physical activity breast cancer home training Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Nicole Tubiana-Mathieu Thibault Cornette Stephane Mandigout Sophie Leobon François Vincent Laurence Venat Elise Deluche Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
description |
Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized clinical trials underwent the CPET and 6MWT before and after adjuvant therapy. Of these patients, 85 had performed APA, and 53 had received only the usual therapy. HRs were recorded during the two tests. Results: Before starting chemotherapy, good agreement (intraclass correlation (ICC) 0.69; confidence interval at 95% IC<sub>0.95</sub> (0.591–0.769); <i>p</i> < 0.001) and a moderate correlation were evident between the 6MWT-HR and ventilatory threshold HR of the CPET (r = 0.70; <i>p</i> < 0.001). Good agreement and a high positive correlation were noted only in the group who engaged in APA (ICC 0.77; IC<sub>0.95</sub> (0.659–0.848); <i>p</i> < 0.001; r = 0.8; <i>p</i> < 0.01); moderate agreement and a moderate positive correlation were apparent in the control group (ICC 0.57; IC<sub>0.95</sub> (0.329–0.74); <i>p</i> < 0.001; r = 0.6; <i>p</i> < 0.01). The correlations were independent of age and body mass index. Conclusions: The 6MWT-HR can be used to prescribe exercise intensity for breast cancer patients both before and after specific treatment with concomitant APA. |
format |
article |
author |
Nicole Tubiana-Mathieu Thibault Cornette Stephane Mandigout Sophie Leobon François Vincent Laurence Venat Elise Deluche |
author_facet |
Nicole Tubiana-Mathieu Thibault Cornette Stephane Mandigout Sophie Leobon François Vincent Laurence Venat Elise Deluche |
author_sort |
Nicole Tubiana-Mathieu |
title |
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
title_short |
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
title_full |
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
title_fullStr |
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
title_full_unstemmed |
Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer? |
title_sort |
can the six-minute walk test be used to individualize physical activity intensity in patients with breast cancer? |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/6a7d92086b044f65b70ec44572b7db46 |
work_keys_str_mv |
AT nicoletubianamathieu canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT thibaultcornette canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT stephanemandigout canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT sophieleobon canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT francoisvincent canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT laurencevenat canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer AT elisedeluche canthesixminutewalktestbeusedtoindividualizephysicalactivityintensityinpatientswithbreastcancer |
_version_ |
1718412716625887232 |